Sigma Planning Corp’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Other funds holding PJP
BCI
PAM
Sigma Planning Corp's PJP Position: Q4 2019 in Review
Sigma Planning Corp sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2019, closing a stake of 3,535 shares — an estimated $200K sold.
Sigma Planning Corp first reported a position in PJP in Q4 2014 and held it in 20 quarters. The position peaked at $1.02M in Q2 2015. 93 funds tracked by Wall St. Rank hold PJP as of Q4 2019.
- Sigma Planning Corp reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2019 after selling out during the quarter.
- Sigma Planning Corp sold 3,535 Invesco Pharmaceuticals ETF shares in Q4 2019, an estimated $200K.
- Sigma Planning Corp first reported a position in Invesco Pharmaceuticals ETF in Q4 2014 and held it in 20 quarters.
- Sigma Planning Corp's Invesco Pharmaceuticals ETF position peaked at $1.02M in Q2 2015.
- 93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2019.
Based on Sigma Planning Corp's 13F filing for Q4 2019, filed 3 Feb 2020.